Education
About Us
Working with TipRanks
Follow Us
Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
Earnings Data
Report Date
Mar 09, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.55Last Year’s EPS
-1.1Same Quarter Last Year
Strong Buy
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Syndax showed strong revenue growth and successful product launches, with Revuforj expanding its market potential significantly through an FDA approval. However, temporary treatment pauses and higher gross to net adjustments posed challenges in realizing full revenue potential.Company Guidance
Strong Revenue Growth
Syndax reported $45.9 million in total revenue for the third quarter, representing a strong 21% growth over the prior quarter.
Revuforj and Niktimvo Launch Success
Revuforj net revenue was $32 million in Q3, up 12% from the prior quarter. Niktimvo reported a 27% increase in net revenue over the prior quarter, with annualizing sales nearly reaching $200 million.
FDA Approval for Revuforj
Revuforj received FDA approval for relapsed/refractory NPM1 mutated AML, tripling the addressable patient population.
Positive Clinical Data
Real-world data from Moffitt Cancer Center showed 79% overall response rate for Revuforj, with significant MRD negativity.
SNDX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SNDX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 03, 2025 | $13.76 | $15.35 | +11.56% |
Aug 04, 2025 | $10.38 | $12.57 | +21.10% |
May 05, 2025 | $13.57 | $10.64 | -21.59% |
Mar 03, 2025 | $15.64 | $15.48 | -1.02% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Syndax Pharmaceuticals Inc (SNDX) report earnings?
Syndax Pharmaceuticals Inc (SNDX) is schdueled to report earning on Mar 09, 2026, After Close (Confirmed).
What is Syndax Pharmaceuticals Inc (SNDX) earnings time?
Syndax Pharmaceuticals Inc (SNDX) earnings time is at Mar 09, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SNDX EPS forecast?
SNDX EPS forecast for the fiscal quarter 2025 (Q4) is -0.55.